The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Most associate sleep apnea with snoring, but it’s the sound of silence doctors say patients should be concerned with.

AD109 is an investigational oral therapy that combines aroxybutynin, an antimuscarinic, with atomoxetine, a selective norepinephrine reuptake inhibitor.

If you have oily skin and are prone to blemishes, Dr. Nazarian recommends this peel-off mask. “This mask contains ...